SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Guj. Themis Biosyn - Quaterly Results

26 Jul 2024 Evaluate
The sales for the June 2024 quarter moved down to Rs. 388.27 millions as compared to Rs. 495.88 millions during the year-ago period.Net profit declined -25.30% to Rs. 132.37 millions from Rs. 177.21 millions.A decline of 190.75 millions was observed in the OP in the quarter ended June 2024 from 245.81 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 388.27 495.88 -21.70 388.27 495.88 -21.70 1698.22 1483.85 14.45
Other Income 5.24 10.75 -51.26 5.24 10.75 -51.26 43.66 65.88 -33.73
PBIDT 190.75 245.81 -22.40 190.75 245.81 -22.40 831.00 802.17 3.59
Interest 0.66 0.25 164.00 0.66 0.25 164.00 2.29 1.76 30.11
PBDT 190.09 245.56 -22.59 190.09 245.56 -22.59 828.71 800.41 3.54
Depreciation 11.48 7.49 53.27 11.48 7.49 53.27 35.36 25.76 37.27
PBT 178.61 238.07 -24.98 178.61 238.07 -24.98 793.35 774.65 2.41
TAX 46.24 60.86 -24.02 46.24 60.86 -24.02 201.71 194.96 3.46
Deferred Tax 0.53 0.96 -44.79 0.53 0.96 -44.79 3.75 2.55 47.06
PAT 132.37 177.21 -25.30 132.37 177.21 -25.30 591.64 579.69 2.06
Equity 72.64 72.64 0.00 72.64 72.64 0.00 72.64 72.64 0.00
PBIDTM(%) 49.13 49.57 -0.89 49.13 49.57 -0.89 48.93 54.06 -9.48

Guj. Themis Biosyn Share Price

319.45 15.45 (5.08%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×